U0126-EtOH
目录号:S1102 Purity: 99.98%
U0126-EtOH是一种高度选择性的MEK1/2抑制剂,无细胞试验中IC50为0.07 μM/0.06 μM,作用于ΔN3-S218E/S222D MEK的亲和力比PD098059强100倍。U0126可抑制细胞自噬和线粒体自噬并具有抗病毒的活性。
CAS: 1173097-76-1
客户使用Selleck的U0126-EtOH发表文献766篇
- Gut, 2024 gutjnl-2023-330390
- Signal Transduct Target Ther, 2022 7(1):317
- Gut, 2021 gutjnl-2020-322744
- Signal Transduct Target Ther, 2020
- Cancer Discov, 2020 10(3):382-393
- Nature, 2019 571(7763):127-131
- Nature, 2019 569(7757):509-513
- Nature, 2019 575(7783):523-527
- Cancer Cell, 2019 35(5):798-815.e5
- Cell Mol Immunol, 2019 16(1):75-86
- Cell Mol Immunol, 2019 10.1038/s41423-019-0281-6
- Nat Cell Biol, 2019 21(8):1027-1040
- Cell, 2018 174(6):1477-1491
- Science, 2018 361(6405)
- Nat Genet, 2018 50(2):206-218
- Cancer Discov, 2018 8(10):1237-1249
- Gastroenterology, 2017 153(1):277-291
- Gut, 2017 66(6):1106-1115
- Blood, 2017 130(18):1995-2005
- Nature, 2016 24;539(7630):570-574.
- Cancer Cell, 2016 29(4):563-573
- Cancer Cell, 2015
- Cell Res, 2015 10.1038/cr.2015.30
- Mol Cancer, 2015 14:59
- Mol Cancer, 2015 14:56
- Mol Cancer, 2014 13:176
- Cell, 2013 9;153(4):840-54.
- Blood, 2013 122(9):1621-33
- Nat Genet, 2011 44(2):133-9
- MedComm (2020), 2024 5(5):e525
- Int J Biol Sci, 2024 20(6):2202-2218
- Cell Death Dis, 2024 15(1):31
- Cell Rep, 2024 43(7):114454
- Cell Mol Life Sci, 2024 81(1):152
- Cell Mol Life Sci, 2024 81(1):59
- PLoS Pathog, 2024 20(11):e1012747
- Mol Oncol, 2024 10.1002/1878-0261.13716
- mBio, 2024 e0313623.
- Neural Regen Res, 2024 19(5):1142-1149
- Cells, 2024 13(14)1222
- iScience, 2024 27(3):109057
- Int J Mol Sci, 2024 25(4)2408
- Am J Cancer Res, 2024 14(3):934-958
- Front Microbiol, 2024 15:1410504
- Cancers (Basel), 2024 16(21)3701
- Aging (Albany NY), 2024 16(19):12850-12865
- Neurobiol Stress, 2024 28:100593
- Neoplasia, 2024 52:100999
- Sci Rep, 2024 14(1):9440
- Oncol Rep, 2024 52(3)122
- ACS Omega, 2024 9(37):38477-38489
- Heliyon, 2024 10(12):e33132
- Anticancer Res, 2024 44(12):5271-5282
- Research Square, 2024 10.21203/rs.3.rs-3480364/v1
- bioRxiv, 2024 2024.01.17.575938
- J Extracell Biol, 2024 3(1):e139
- Nat Commun, 2023 14(1):478
- Nat Commun, 2023 14(1):2402
- Nat Commun, 2023 14(1):4062
- Redox Biol, 2023 67:102877
- J Exp Clin Cancer Res, 2023 42(1):1
- Cell Rep, 2023 42(6):112647
- Mol Ther Nucleic Acids, 2023 31:421-436
- J Transl Med, 2023 21(1):530
- J Transl Med, 2023 21(1):426
- Front Immunol, 2023 14:1192861
- Cell Mol Gastroenterol Hepatol, 2023 10.1016/j.jcmgh.2023.10.007
- Antioxidants (Basel), 2023 12(1)175
- Ecotoxicol Environ Saf, 2023 254:114704
- Ecotoxicol Environ Saf, 2023 259:115043
- Cancer Gene Ther, 2023 10.1038/s41417-023-00648-5
- Oncogenesis, 2023 10.1038/s41389-023-00496-w
- iScience, 2023 26(6):106924
- iScience, 2023 26(5):106639
- iScience, 2023 26(10):107940
- Mol Ther Oncolytics, 2023 29:17-29
- Int J Mol Sci, 2023 24(2)1015
- Int J Mol Sci, 2023 24(4)3823
- Int J Mol Sci, 2023 24(7)6353
- Mar Drugs, 2023 21(2)77
- Am J Cancer Res, 2023 13(2):436-451
- Eur J Pharmacol, 2023 941:175492
- Biomedicines, 2023 11(7)1894
- Molecules, 2023 28(4)1873
- Development, 2023 150(20)dev201704
- Mol Hum Reprod, 2023 30(1)gaad042
- J Cell Sci, 2023 136(4)jcs259788
- J Dent Sci, 2023 18(1):87-94
- Cell Adh Migr, 2023 10.1080/19336918.2023.2271260
- Curr Issues Mol Biol, 2023 45(7):6154-6169
- Heliyon, 2023 9(7):e18289
- Nat Commun, 2022 13(1):3706
- Nat Commun, 2022 13(1):3732
- Mol Cell, 2022 82(20):3919-3931.e7
- Adv Sci (Weinh), 2022 10.1002/advs.202104055
- Emerg Microbes Infect, 2022 11(1):1717-1729
- Exp Mol Med, 2022 10.1038/s12276-022-00771-7
- Redox Biol, 2022 54:102384
- J Adv Res, 2022 S2090-1232(22)00254-5
- Mol Syst Biol, 2022 18(6):e10670
- Int J Biol Sci, 2022 18(1):349-359
- Cell Death Dis, 2022 13(6):571
- Br J Cancer, 2022 10.1038/s41416-022-01973-6
- Cell Rep, 2022 40(1):111035
- Cell Rep, 2022 38(11):110522
- Cell Prolif, 2022 e13315
- Cell Commun Signal, 2022 20(1):72
- JCI Insight, 2022 7(3)e145475
- Oncogene, 2022 10.1038/s41388-022-02197-x
- Elife, 2022 11e76183
- Elife, 2022 11e84171
- Cell Biosci, 2022 12(1):25
- Oxid Med Cell Longev, 2022 2022:9982449
- Front Immunol, 2022 13:762080
- Cell Mol Gastroenterol Hepatol, 2022 S2352-345X(22)00168-0
- Apoptosis, 2022 10.1007/s10495-022-01714-3
- Antioxidants -Basel, 2022 11-91741
- Ecotoxicol Environ Saf, 2022 247:114263
- Transl Psychiatry, 2022 12(1):458
- Cancer Gene Ther, 2022 10.1038/s41417-022-00471-4
- mBio, 2022 13(3):e0061522
- Biochim Biophys Acta Mol Basis Dis, 2022 1868(9):166447
- Cells, 2022 11(19)3129
- Cells, 2022 11(21)3375
- Commun Biol, 2022 5(1):186
- Stroke Vasc Neurol, 2022 svn-2022-001700
- Commun Biol, 2022 5(1):726
- iScience, 2022 25(7):104603
- Mol Med, 2022 28(1):142
- Int J Mol Sci, 2022 23(14)7631
- Int Immunopharmacol, 2022 105:108552
- Front Pharmacol, 2022 13:865715
- Front Cell Dev Biol, 2022 10:1000575
- J Leukoc Biol, 2022 10.1002/JLB.2A0421-221R
- Mar Drugs, 2022 20(6)378
- Front Cell Neurosci, 2022 16:989945
- J Neurosci, 2022 JN-RM-1133-21
- Front Microbiol, 2022 13:968872
- Mol Cancer Res, 2022 molcanres.0090.2022-1-28 10:45:29.413
- J Biol Chem, 2022 298(4):101748
- J Biol Chem, 2022 298(11):102588
- Cell Signal, 2022 94:110311
- J Biol Chem, 2022 S0021-9258(22)00494-X
- Sci Rep, 2022 12(1):704
- Invest Ophthalmol Vis Sci, 2022 63(10):14
- Stem Cells Int, 2022 2022:2401693
- Front Physiol, 2022 13:929926
- Insect Sci, 2022 10.1111/1744-7917.13045
- BMC Cancer, 2022 22(1):749
- Microbiol Spectr, 2022 e0188121
- Acta Biochim Biophys Sin (Shanghai), 2022 54(4):494-503
- Int J Med Sci, 2022 19(8):1307-1319
- Toxicol Lett, 2022 358:48-58
- J Periodontal Res, 2022 10.1111/jre.12986
- Adipocyte, 2022 11(1):588-600
- Brain Sci, 2022 12(7)813
- Immun Inflamm Dis, 2022 10(12):e735
- J Mol Neurosci, 2022 1-20
- Cancer Chemother Pharmacol, 2022 89(3):401-411
- Evid Based Complement Alternat Med, 2022 2022:1525110
- J Orthop Res, 2022 10.1002/jor.25273
- Noncoding RNA, 2022 8(5)62
- J Am Chem Soc, 2021 10.1021/jacs.1c05386
- Autophagy, 2021 1-19
- Cell Death Differ, 2021 28(4):1317-1332
- Theranostics, 2021 11(3):996-1015
- Cancer Res, 2021 81(12):3174-3186
- Sci Total Environ, 2021 775:145814
- Cancer Lett, 2021 509:13-25
- Cancer Lett, 2021 S0304-3835(21)00581-4
- ACS Appl Mater Interfaces, 2021 13(1):97-111
- Cell Death Dis, 2021 12(2):186
- Cell Death Dis, 2021 12(2):203
- Environ Pollut, 2021 275:116636
- Cell Rep, 2021 37(1):109774
- Mol Ther Nucleic Acids, 2021 23:294-309
- Cell Rep, 2021 35(6):109100
- Cell Rep, 2021 35(5):109069
- Food Chem, 2021 348:129111
- Cell Rep, 2021 36(1):109311
- Cell Mol Life Sci, 2021 10.1007/s00018-021-04009-z
- Phytomedicine, 2021 85:153549
- Stem Cell Res Ther, 2021 12(1):268
- Front Immunol, 2021 12:752466
- Front Immunol, 2021 12:737988
- Cell Death Discov, 2021 7(1):32
- Ecotoxicol Environ Saf, 2021 211:111900
- Ecotoxicol Environ Saf, 2021 208:111693
- Mol Oncol, 2021 10.1002/1878-0261.13153
- Hemasphere, 2021 5(7):e593
- Front Pharmacol, 2021 12:646331
- Int J Mol Sci, 2021 22(14)7540
- J Cell Physiol, 2021 10.1002/jcp.30528
- Front Pharmacol, 2021 12:684243
- Int Immunopharmacol, 2021 103:108456
- Int Immunopharmacol, 2021 94:107458
- Front Pharmacol, 2021 12:784329
- Front Cell Dev Biol, 2021 9:634371
- FEBS J, 2021 288(18):5406-5429
- CNS Neurosci Ther, 2021 10.1111/cns.13708
- Int J Mol Med, 2021 48(4)190
- J Virol, 2021 JVI.00180-21
- J Cell Mol Med, 2021 10.1111/jcmm.16697
- Am J Cancer Res, 2021 11(12):5992-6003
- J Cell Mol Med, 2021 10.1111/jcmm.16990
- Eur J Pharmacol, 2021 911:174526
- J Biol Chem, 2021 S0021-9258(21)00206-4
- FASEB J, 2021 35(10):e21851
- Biomedicines, 2021 9(9)1230
- Sci Rep, 2021 11(1):6381
- Sci Rep, 2021 11(1):9161
- J Inflamm Res, 2021 14:2897-2911
- Front Neurosci, 2021 15:525615
- Environ Toxicol Pharmacol, 2021 83:103586
- J Immunol Res, 2021 2021:8483938
- Biosci Rep, 2021 BSR20211067
- Cancer Med, 2021 10.1002/cam4.4066
- Front Physiol, 2021 12:674430
- J Cancer, 2021 12(2):518-529
- Biochimie, 2021 184:8-17
- BMB Rep, 2021 54(5):272-277
- Toxicol Appl Pharmacol, 2021 415:115447
- Toxicol Sci, 2021 kfab033
- PLoS One, 2021 16(2):e0247190
- Exp Cell Res, 2021 402(2):112575
- Cell Tissue Res, 2021 10.1007/s00441-020-03355-x
- Gene, 2021 812:146100
- Toxicol Lett, 2021 350:62-70
- Mol Med Rep, 2021 24(3)636
- Mol Med Rep, 2021 23(6)465
- Vet Microbiol, 2021 262:109237
- Dig Dis Sci, 2021 10.1007/s10620-021-07250-5
- Dev Comp Immunol, 2021 128:104327
- Exp Ther Med, 2021 21(6):620
- Leuk Lymphoma, 2021 1-12
- Curr Med Sci, 2021 41(3):454-464
- Sci Adv, 2021 7(36):eabi9787
- Biosci Biotechnol Biochem, 2021 85(3):675-686
- Folia Biol (Praha), 2021 67(3):118-125
- Curr Protoc, 2021 1(6):e180
- Nat Commun, 2020 11(1):6196
- Adv Sci (Weinh), 2020 7(16):2000925
- Autophagy, 2020 16(6):1061-1076
- Autophagy, 2020 10.1080/15548627.2020.1850609
- Theranostics, 2020 10(20):9332-9347
- Cancer Res, 2020 80(22):5035-5050
- EMBO Mol Med, 2020 12(4):e11177
- EBioMedicine, 2020 52:102635
- Metabolism, 2020 15;107:154241
- Cancer Lett, 2020 S0304-3835(20)30621-2
- J Neuroinflammation, 2020 17(1):75
- Cell Death Dis, 2020 11(8):709
- Cell Rep, 2020 31(13):107801
- Cell Rep, 2020 30(6):1780-1797
- Cell Rep, 2020 31(2):107514
- Cell Prolif, 2020 e12869
- Oncogene, 2020 10.1038/s41388-020-01403-y
- Oncogene, 2020 39(15):3218-3225
- Aging Cell, 2020 19(9):e13210
- Elife, 2020 9:e53367
- Biomed Pharmacother, 2020 121:109669
- Oxid Med Cell Longev, 2020
- NPJ Regen Med, 2020 5(1):18
- Oncoimmunology, 2020 9(1):1758003
- Antioxidants (Basel), 2020 9(3)
- Antioxid Redox Signal, 2020 10.1089/ars.2019.7840
- Mol Oncol, 2020 14(12):3153-3168
- Cells, 2020 9(9):E1927
- J Clin Endocrinol Metab, 2020 dgaa656
- Mol Ther Oncolytics, 2020 29;17:21-30
- Cancer Sci, 2020 111(7):2336-2348
- J Cell Physiol, 2020 10.1002/jcp.30134
- Int J Mol Sci, 2020 21(23)E9240
- J Cell Physiol, 2020 235(5):4481-4493
- Int J Mol Sci, 2020 21(1)
- Int J Mol Sci, 2020 21(14):4956
- Biomolecules, 2020 10(4)E580
- Front Cell Dev Biol, 2020 7:397
- Virol Sin, 2020 10.1007/s12250-020-00320-4
- Am J Physiol Cell Physiol, 2020 10.1152/ajpcell.00290.2020
- J Mol Cell Biol, 2020 22;12(1):55-70
- Am J Physiol Cell Physiol, 2020 318(3):C664-C674
- J Virol, 2020 JVI.01413-20
- J Virol, 2020 JVI.02001-20
- Oncotarget, 2020 11(7):755-757
- J Neurosci, 2020 40(34):6522-6535
- Aging (Albany NY), 2020 12(9):8167-8190
- Cancers (Basel), 2020 8;12(4) pii: E909
- Inflammation, 2020 10.1007
- Lab Invest, 2020 100(3):438-453
- Transl Oncol, 2020 13(2):441-451
- Eur J Pharmacol, 2020 867:172823
- Asian Pac J Allergy Immunol, 2020 38(1):52-63
- Antimicrob Agents Chemother, 2020 1;AAC.00341-20
- Cell Signal, 2020 73:109702
- J Biol Chem, 2020 30 pii: jbc
- Fish Shellfish Immunol, 2020 10.1016/j.fsi.2020.03.056
- Front Oncol, 2020 10:589112
- Ann Transl Med, 2020 8(20):1305
- Sci Rep, 2020 10(1):13834
- Chin J Nat Med, 2020 18(3):226-233
- Sci Rep, 2020 10(1):13124
- Environ Toxicol, 2020 9
- RNA, 2020 13 pii: rna 73528 119
- Genomics, 2020 112(2):1065-1076
- Cell Cycle, 2020 19(4):464-478
- Oncol Rep, 2020 43(5):1558-1568
- Mol Cell Endocrinol, 2020 503:110671
- Front Physiol, 2020 11:555006
- Biol Trace Elem Res, 2020 10.1007
- PLoS One, 2020 15(6):e0234708
- Int J Med Sci, 2020 17(18):3174-3189
- J Cancer Res Clin Oncol, 2020 146(3):593-604
- Adipocyte, 2020 9(1):142-152
- J Mol Neurosci, 2020 10.1007/s12031-020-01735-0
- Biochem Biophys Res Commun, 2020 S0006-291X(20)32148-3
- Animals (Basel), 2020 28;10(6):E930
- Evid Based Complement Alternat Med, 2020 2020:2861978
- Anticancer Drugs, 2020 31(10):1026-1037
- Cytotechnology, 2020 10.1007
- Sci Adv, 2020 1;6(18):eaaz7001
- Med Mol Morphol, 2020 Apr 6
- Exp Lung Res, 2020 1-11
- bioRxiv, 2020 2020/9/20.4.7.30734
- J Dev Biol, 2020 8(3):E12
- Hepatology, 2019 70(1):198-214
- Autophagy, 2019 10.1080/15548627.2019.1628540
- J Autoimmun, 2019 10.1016/j.jaut.2019.102358
- Cell Death Differ, 2019 10.1038/s41418-019-0361-2
- Redox Biol, 2019 21:101061
- Redox Biol, 2019 24:101189
- J Exp Clin Cancer Res, 2019 38(1):314
- Carbohydr Polym, 2019 206:706-715
- Carbohydr Polym, 2019 214:34-43
- Proc Natl Acad Sci U S A, 2019 116(8):2967-2976
- Proc Natl Acad Sci USA, 2019
- Cancer Immunol Res, 2019
- J Neuroinflammation, 2019 16(1):84
- Cell Death Dis, 2019 10(8):606
- Cell Death Dis, 2019 10(11):805
- Cell Death Dis, 2019 10(6):399
- Cell Death Dis, 2019 10(12):891
- Cell Death Dis, 2019 10(3):166
- Cell Death Dis, 2019 10(10):738
- Cell Death Dis, 2019 10(7):526
- Cell Death Dis, 2019 10(4):319
- Cell Death Dis, 2019 10(3):191
- Mol Ther Nucleic Acids, 2019 16:707-720
- Cell Chem Biol, 2019 26(8):1122-1132
- Cell Prolif, 2019 52(6):e12680
- Cell Commun Signal, 2019 17(1):31
- Int J Biol Macromol, 2019 138:125-134
- Oncogene, 2019 38(27):5500-5515
- Oncogene, 2019 38(10):1639-1650
- Oncogene, 2019 38(15):2690-2705
- J Dent Res, 2019 98(10):1131-1139
- Stem Cell Res Ther, 2019 10(1):222
- Breast Cancer Res, 2019 21(1):11
- Free Radic Biol Med, 2019 141:21-33
- Br J Pharmacol, 2019 176(22):4388-4401
- Ecotoxicol Environ Saf, 2019 171:467-474
- Mol Oncol, 2019 13(2):228-245
- Mol Oncol, 2019 13(9):1959-1975
- Thyroid, 2019 29(1):79-92
- Cell Biol Toxicol, 2019 10.1007/s10565-019-09508-1
- Life Sci, 2019 229:173-179
- Neurobiol Dis, 2019 124:322-334
- Colloids Surf B Biointerfaces, 2019 179:309-316
- Biochem Pharmacol, 2019 170:113642
- Biochem Pharmacol, 2019 10.1016/j.bcp.2019.07.008
- Cancer Sci, 2019
- J Cell Physiol, 2019 234(6):9475-9485
- Front Pharmacol, 2019 0.86041666667
- Int J Mol Sci, 2019 20(10)
- J Cell Physiol, 2019 234(4):3685-3696
- J Cell Physiol, 2019 10.1002/jcp.28810
- Front Pharmacol, 2019 10:356
- J Cell Mol Med, 2019 23(8):5303-5316
- J Cell Mol Med, 2019 23(2):920-933
- Int J Oncol, 2019 55(3):684-696
- Int J Oncol, 2019 54(5):1545-1554
- Chem Biol Interact, 2019 310:108741
- Inflammation, 2019 42(2):413-425
- Drug Des Devel Ther, 2019 13:1221-1231
- Cell Signal, 2019 54:170-178
- J Biol Chem, 2019 294(21):8384-8394
- FASEB J, 2019 33(10):10833-10843
- Endocrinology, 2019 160(11):2692-2708
- Cell Signal, 2019 61:39-47
- FASEB J, 2019 33(6):7213-7224
- FASEB J, 2019 33(10):11137-11147
- J Neurochem, 2019 10.1111/jnc.14827
- Neuropharmacology, 2019 148:31-39
- Mediators Inflamm, 2019 2019:6085801
- J Immunol, 2019 10.4049/jimmunol.1900169
- Pigment Cell Melanoma Res, 2019 32(2):280-291
- Cell Cycle, 2019 18(5):596-604
- Stem Cells Int, 2019 2019:4793518
- Oncol Rep, 2019 41(2):1424
- Onco Targets Ther, 2019 12:1825-1839
- J Cell Sci, 2019 132(15)jcs228213
- Int J Biochem Cell Biol, 2019 116:105610
- Immunol Cell Biol, 2019 97(4):403-415
- BMC Cancer, 2019 19(1):936
- BMC Cancer, 2019 19(1):1192
- Cytokine, 2019 119:81-89
- PLoS One, 2019 14(9):e0222559
- Exp Cell Res, 2019 376(2):105-113
- Exp Cell Res, 2019 375(2):41-50
- Biomed Res Int, 2019 2019:3851718
- Metab Brain Dis, 2019 34(5):1355-1363
- Mol Immunol, 2019 107:21-28
- Biol Reprod, 2019 100(5):1344-1355
- FEBS Lett, 2019 593(14):1751-1762
- Mol Med Rep, 2019 19(2):1092-1100
- Cancer Manag Res, 2019 11:3493-3509
- Cancer Manag Res, 2019 11:5501-5511
- Free Radic Res, 2019 53(3):348-358
- Pediatr Blood Cancer, 2019 66(8):e27790
- Med Sci Monit, 2019 25:3815-3824
- Med Sci Monit, 2019 25:6836-6845
- Biochem Biophys Res Commun, 2019 511(4):847-854
- Arch Oral Biol, 2019 104:123-132
- Integr Cancer Ther, 2019 18:1534735418822120
- Brain Res, 2019 15;1721:146347
- Oncol Lett, 2019 18(2):1793-1799
- Immunobiology, 2019 224(3):388-396
- Pathol Oncol Res, 2019 10.1007/s12253-019-00746-6
- FEBS Open Bio, 2019 9(2):335-347
- Mol Reprod Dev, 2019 86(6):714-726
- Am J Transl Res, 2019 11(2):733-743
- Neurourol Urodyn, 2019 38(6):1504-1516
- Chem Pharm Bull (Tokyo), 2019 67(3):244-252
- Nat Commun, 2018 9(1):159
- Cancer Commun (Lond), 2018
- Theranostics, 2018 8(10):2846-2861
- J Exp Clin Cancer Res, 2018 37(1):135
- Proc Natl Acad Sci U S A, 2018 115(42):E9869-E9878
- J Pineal Res, 2018 65(3):e12502
- Cancer Immunol Res, 2018 6(10):1220-1233
- Cancer Lett, 2018
- Cancer Lett, 2018 418:135-146
- Cell Death Dis, 2018 9(2):161
- Cell Death Dis, 2018 9(6):700
- Cell Death Dis, 2018 9(3):352
- Cell Death Dis, 2018 9(10):1036
- Cell Death Dis, 2018 9(3):371
- Cell Rep, 2018 23(13):3798-3812
- Food Chem, 2018 240:534-543
- Cell Rep, 2018
- Oncogene, 2018 37(3):377-388
- Diabetes, 2018 67(7):1441-1453
- Blood Adv, 2018 26;2(12):1439-1448
- Br J Pharmacol, 2018 175(10):1637-1653
- Cell Death Discov, 2018 4:34
- Ecotoxicol Environ Saf, 2018 165:144-152
- PLoS Pathog, 2018 14(8):e1007266
- Br J Haematol, 2018 182(6):921-924
- Br J Haematol, 2018 183(3):428-444
- Cancer Cell Int, 2018 18:209
- Cancer Immunol Immunother, 2018 67(2):271-283
- Cancer Cell Int, 2018 18:149
- Cancer Sci, 2018 109(6):1834-1842
- Int J Mol Sci, 2018 19(3)E734
- J Cell Physiol, 2018 233(4):3066-3079
- J Cell Physiol, 2018 233(1):596-606
- Front Pharmacol, 2018
- J Cell Physiol, 2018 233(9):7268-7278
- Front Pharmacol, 2018 8:988
- Front Pharmacol, 2018 9:21
- J Ethnopharmacol, 2018 224:554-562
- J Virol, 2018 92(4)e01463-17
- Int J Mol Med, 2018 42(4):1955-1966
- J Cell Mol Med, 2018 22(2):1283-1291
- Cancers (Basel), 2018 10(12)
- Int J Oncol, 2018 52(4):1105-1116
- Bioorg Chem, 2018 81:382-388
- Transl Oncol, 2018 11(4):988-998
- Eur J Pharmacol, 2018 838:129-137
- FASEB J, 2018 32(2):838-849
- Biochim Biophys Acta Mol Cell Biol Lipids, 2018 1863(2):177-190
- J Neurochem, 2018 147(1):40-57
- Sci Rep, 2018 8(1):5074
- Molecules, 2018 23(8)E1992
- Sci Rep, 2018 8(1):6883
- Sci Rep, 2018 8(1):10923
- Neurochem Res, 2018 43(8):1631-1640
- Cell Physiol Biochem, 2018 47(4):1617-1629
- Cell Physiol Biochem, 2018 47(1):151-160
- Cell Physiol Biochem, 2018 47(5):1769-1784
- Cell Physiol Biochem, 2018 51(2):589-609
- Mol Cell Biochem, 2018 447(1-2):137-149
- World J Gastroenterol, 2018 24(34):3884-3897
- Oncol Rep, 2018 40(2):726-736
- Oncol Rep, 2018 40(2):682-692
- Oncol Rep, 2018 39(4):1910-1918
- Oncol Rep, 2018 40(4):2325-2333
- Cancer Med, 2018 7(3):913-921
- Onco Targets Ther, 2018 11:8915-8923
- Arch Biochem Biophys, 2018 650:1-13
- Toxicol Appl Pharmacol, 2018 359:1-11
- PLoS One, 2018 13(7):e0200878
- PLoS One, 2018 13(11):e0207607
- Biomed Res Int, 2018 2018:2548378
- Mol Brain, 2018 11(1):35
- Gene, 2018
- Metallomics, 2018 10(3):486-495
- Mol Med Rep, 2018 17(1):447-451
- Mol Biol Cell, 2018 29(3):356-362
- J Neuroimmunol, 2018 316:17-22
- Mol Biol Cell, 2018 29(8):975-987
- Pediatr Blood Cancer, 2018 65(9):e27237
- Infect Immun, 2018 22;86(9):e00233-18
- Infect Immun, 2018 19;87(1):e00508-18
- Biochem Biophys Res Commun, 2018 501(3):791-799
- Int J Chron Obstruct Pulmon Dis, 2018 13:703-715
- Toxicon, 2018 155:1-8
- Exp Ther Med, 2018 16(4):3211-3219
- Biol Open, 2018
- Growth Factors, 2018 36(3-4):141-152
- Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2018 34(6):536-540
- Nan Fang Yi Ke Da Xue Xue Bao, 2018 38(9):1025-1031
- Nat Commun, 2017 8(1):1580
- Mol Cell, 2017 68(2):323-335
- Mol Cell, 2017 68(6):1134-1146
- J Clin Invest, 2017 127(1):153-168
- Brain Behav Immun, 2017 62:64-77
- Nucleic Acids Res, 2017 45(16):9654-9678
- Autophagy, 2017 13(8):1364-1385
- Autophagy, 2017 13(7):1093-1112
- Cell Death Differ, 2017 24(5):785-797
- Cancer Res, 2017 77(22):6215-6225
- EBioMedicine, 2017 23:88-99
- Proc Natl Acad Sci U S A, 2017 114(6):E980-E989
- J Thromb Haemost, 2017 15(8):1679-1688
- J Neuroinflammation, 2017 14(1):67
- Cell Death Dis, 2017 8(5):e2817
- Cell Death Dis, 2017
- Cell Death Dis, 2017 8(9):e3050
- Acta Pharmacol Sin, 2017 10.1038/aps.2017.53
- Mucosal Immunol, 2017 10(6):1491-1503
- Biomed Pharmacother, 2017 89:983-990
- Biomed Pharmacother, 2017 89:1277-1285
- Biomed Pharmacother, 2017 85:313-322
- Br J Pharmacol, 2017 174(17):2941-2961
- Front Immunol, 2017 9:2847
- Br J Pharmacol, 2017 174(8):641-656
- Oncoimmunology, 2017 6(9):e1333213
- Oncoimmunology, 2017 7(3):e1408745
- PLoS Pathog, 2017 13(4):e1006321
- Int J Mol Sci, 2017 18(12)
- FEBS J, 2017 284(17):2856-2869
- J Ethnopharmacol, 2017 200:165-173
- Oncotarget, 2017 8(26):42300-42313
- Oncotarget, 2017 8(33):55084-55093
- Oncotarget, 2017 8(7):10905-10918
- Oncotarget, 2017 8(57):96970-96983
- Oncotarget, 2017 8(42):71642-71656
- Oncotarget, 2017 8(54):92240-92253
- Oncotarget, 2017
- Oncotarget, 2017 8(39):64853-64866
- Oncotarget, 2017 8(61):104216-104226
- J Cell Mol Med, 2017 21(6):1094-1105
- Front Cell Neurosci, 2017 11:218
- Front Microbiol, 2017 8:1393
- Int J Oncol, 2017 50(5):1792-1800
- Biochim Biophys Acta Mol Cell Res, 2017 1864(1):89-100
- Cell Signal, 2017 39:74-83
- J Biol Chem, 2017 292(10):3970-3976
- Sci Rep, 2017 7(1):14416
- Sci Rep, 2017 7(1):5594
- Sci Rep, 2017 7:42939
- Sci Rep, 2017 7:42678
- Sci Rep, 2017 7(1):13846
- Sci Rep, 2017 7:41857
- Sci Rep, 2017 7:45056
- Sci Rep, 2017 7:43385
- Sci Rep, 2017 7:40762
- Cell Physiol Biochem, 2017 44(1):293-302
- Cell Physiol Biochem, 2017 43(5):2133-2142
- Anal Bioanal Chem, 2017 409(8):2163-2178
- J Steroid Biochem Mol Biol, 2017 171:318-327
- Mol Cell Endocrinol, 2017 452:74-83
- Front Physiol, 2017 8:762
- PLoS One, 2017 12(9):e0183972
- Exp Cell Res, 2017 357(2):211-221
- PLoS One, 2017 12(11):e0187700
- Mol Immunol, 2017 87:249-257
- Mol Pharmacol, 2017 91(5):451-463
- J Dig Dis, 2017 18(6):349-358
- Toxicol Lett, 2017 277:32-40
- Appl Physiol Nutr Metab, 2017 42(10):1082-1091
- Biochim Biophys Acta Gen Subj, 2017 1861(5 Pt A):1065-1074
- Oncol Lett, 2017 14(2):1993-2000
- Oncol Lett, 2017 14(1):517-524
- PPAR Res, 2017 2017:4313561
- Oncol Lett, 2017 14(6):7499-7505
- Oncol Lett, 2017 14(3):3089-3095
- Int J Chron Obstruct Pulmon Dis, 2017 12:3341-3351
- Urol Oncol, 2017 35(1):32.e9-32.e16
- Exp Ther Med, 2017 14(5):4547-4553
- Dis Esophagus, 2017 30(2):1-8
- J Thorac Dis, 2017 9(11):4398-4412
- Am J Transl Res, 2017 9(4):1834-1844
- Sci Adv, 2017 3(8):e1700475
- F1000Res, 2017 6:577
- Nat Commun, 2016 7:11371
- Hepatology, 2016 64(5):1637-1651
- J Exp Clin Cancer Res, 2016 35(1):101
- Cancer Res, 2016
- Br J Dermatol, 2016 175(6):1221-1231
- Cancer Lett, 2016 380(1):87-97
- Cell Death Dis, 2016 7(11):e2456
- Cell Death Dis, 2016 7:e2216
- Cell Death Dis, 2016 7(10):e2405
- Oncogene, 2016 35(32):4179-90
- Oncogene, 2016 35(30):3986-94
- Biomed Pharmacother, 2016 84:535-543
- Free Radic Biol Med, 2016 90:230-42
- Apoptosis, 2016 21(1):13-24
- Apoptosis, 2016 21(7):809-24
- Osteoarthritis Cartilage, 2016 24(5):892-901
- Matrix Biol, 2016 51:55-64
- Inflamm Res, 2016 65(3):193-202
- Thyroid, 2016 26(12):1794-1803
- Biofactors, 2016 42(2):212-23
- Clin Sci (Lond), 2016 130(4):289-99
- Front Pharmacol, 2016 7:337
- Int J Mol Med, 2016 38(6):1815-1822
- Oncotarget, 2016 7(15):19948-59
- Oncotarget, 2016 7(1):524-37
- Oncotarget, 2016 7(16):22623-31
- Oncotarget, 2016
- Oncotarget, 2016 7(30):47637-47649
- Oncotarget, 2016
- Oncotarget, 2016 7(26):39473-39485
- Oncotarget, 2016 7(14):18204-18
- Oncotarget, 2016 7(21):31466-83
- Oncotarget, 2016 7(41):67277-67287
- Mol Cell Biol, 2016 36(10):1555-68
- Am J Cancer Res, 2016 6(8):1741-57
- Mol Nutr Food Res, 2016 60(5):1139-49
- Stem Cells, 2016 34(11):2744-2757
- Int J Oncol, 2016 48(5):2015-24
- J Biol Chem, 2016 291(19):10252-62
- Neuropharmacology, 2016 101:98-109
- Sci Rep, 2016 6:37534
- Sci Rep, 2016 6:30904
- Toxicology, 2016 370:106-115
- Invest Ophthalmol Vis Sci, 2016 57(14):6123-6133
- Neurochem Res, 2016 41(8):1969-81
- Mol Cell Biochem, 2016 413(1-2):165-78
- Anal Bioanal Chem, 2016 408(26):7491-503
- J Periodontol, 2016 87(11):e192-e199
- Oncol Rep, 2016 36(1):410-8
- Oncol Rep, 2016 35(5):3009-17
- Oncol Rep, 2016 35(4):2398-404
- Biochem J, 2016 473(13):1895-904
- Biochem J, 2016 473(22):4243-4254
- Arch Biochem Biophys, 2016 609:31-38
- Toxicol Appl Pharmacol, 2016 311:12-25
- Toxicological Sciences, 2016 181–192
- Toxicol Sci, 2016 151(1):181-92
- Toxicol Lett, 2016 264:87-98
- Brain Res, 2016 1;1648(Pt A):90-100
- Int J Endocrinol, 2016 2016:4513051
- Leuk Lymphoma, 2016 57(6):1413-22
- Comp Biochem Physiol A Mol Integr Physiol, 2016 199:95-104
- J Interferon Cytokine Res, 2016 36(9):552-62
- Biomed Rep, 2016 5(1):87-92
- Tumour Biol, 2016 37(7):8587-97
- Tumour Biol, 2016 37(8):10269-78
- Tumour Biol, 2016 37(3):3727-38
- Tumour Biol, 2016 37(4):4991-9
- J Exp Med, 2015 212(6):883-92
- EMBO Mol Med, 2015 7(9):1104-18
- ACS Appl Mater Interfaces, 2015 7(1):1012-20
- Cell Rep, 2015 10.1016/j.celrep.2015.01.014
- Elife, 2015 4:e10510
- J Lipid Res, 2015 56(8):1471-80
- J Invest Dermatol, 2015 135(7):1863-1872
- Hum Reprod, 2015 30(7):1606-16
- J Cell Physiol, 2015 230(6):1332-41
- J Cell Physiol, 2015 230(5):1064-74
- J Virol, 2015 90(4):1918-30
- Oncotarget, 2015 6(30):29335-46
- Oncotarget, 2015
- Oncotarget, 2015 6(10):8244-54
- Oncotarget, 2015 6(38):40907-19
- Oncotarget, 2015 6(28):26373-87
- Oncotarget, 2015 6(16):14165-78
- Oncotarget, 2015 6(15):13550-63
- Oncotarget, 2015 6(17):15551-65
- Oncotarget, 2015
- Am J Cancer Res, 2015 5(9):2660-72
- Int J Oncol, 2015 47(3):1017-24
- J Biol Chem, 2015 290(52):30988-1002
- Biochim Biophys Acta, 2015 1853(11 Pt A):2847-55
- Eur J Pharm Sci, 2015 70C:82-91
- Mol Cell Biochem, 2015 410(1-2):101-10
- Int J Biochem Cell Biol, 2015 60C:34-42
- Arch Biochem Biophys, 2015 10.1016/j.taap.2015.03.018
- Cell Stress Chaperones, 2015 10.1007/s12192-015-0580-5
- PLoS One, 2015 10(8):e0135851
- PLoS One, 2015 10(11):e0143777
- PLoS One, 2015 10(1):e0115523
- PLoS One, 2015 10(4):e0123410
- Cancer Biol Ther, 2015 16(1):106-14
- FEBS Lett, 2015 589(17):2248-56
- Toxicol Lett, 2015 233(2):102-113
- Med Oncol, 2015 32(6):577
- Biochem Biophys Res Commun, 2015 466(4):670-5
- J Mol Neurosci, 2015 57(3):335-51
- Clin Exp Pharmacol Physiol, 2015 42(9):930-939
- Int J Clin Exp Med, 2015 8(5):6687-701
- Int J Clin Exp Med, 2015 8(6):8599-607
- Tumour Biol, 2015 36(2):973-81
- Clin Cancer Res, 2014 20(23):6023-33
- Proc Natl Acad Sci USA, 2014 111(15):E1528-37
- EMBO Mol Med, 2014 6(6):821-34
- Cancer Lett, 2014 355(1):130-40
- Cell Death Dis, 2014 5:e1480
- Oncogene, 2014 33(19):2531-9
- Sci Signal, 2014 7(349):ra103
- Mol Oncol, 2014 8(7):1339-54
- J Cell Physiol, 2014 229(11):1660-72
- Oncotarget, 2014 5(15):6289-99
- Exp Neurol, 2014 263C:39-49
- J Biol Chem, 2014 289(30):20448-20461
- J Cell Commun Signal, 2014 8(4):353-62
- J Cell Biochem, 2014 115(5):874-88
- Brain Res Bull, 2014 107C:69-78
- PLoS One, 2014 9(8):e104364
- PLoS One, 2014 9(12):e114389
- Endocr Res, 2014 10.3109/07435800.2014.966383
- Nat Commun, 2013 4:1735
- Cancer Res, 2013 73(20):6346-58
- Sci Signal, 2013 6(279):ra45
- Sci Signal, 2013
- Cancer Sci, 2013 104(8):1027-32
- Mol Cancer Ther, 2013 12(6):1131-9
- Oncotarget, 2013 4(11):1986-98
- Lung Cancer, 2013 73(3):274-82
- J Biol Chem, 2013 288(24):17713-24
- J Biol Chem, 2013 288(41):29821-35
- Biochim Biophys Acta, 2013 1832(12):1998-2008
- Carcinogenesis, 2013 34(2):268-76
- PLoS One, 2013 8(3):e59879
- PLoS One, 2013 8(5):e63890
- Exp Physiol, 2013 98(9):1349-65
- J Genet Syndr Gene Ther, 2013 4
- Genetic Syndromes & Gene Therapy, 2013 4:6
- Cell Death Differ, 2012 19(12):1908-16
- J Natl Cancer Inst, 2012 104(21):1673-9
- Cancer Lett, 2012 316(1):77-84
- J Invest Dermatol, 2012 132(12):2780-90
- J Biol Chem, 2012 287(23):19242-54
- J Cell Biochem, 2012 114(6):1322-35
- PLoS One, 2012 7(9):e42441
- PLoS One, 2012 7(2):e31428
- J Biomol Screen, 2012 17(6):813-21
- Biomaterials, 2011 32(30):7524-31
- Sci Signal, 2010 3(149):ra84
- J Immunol, 2010 184(12):7219-28
- Methods Mol Biol, 2010 661:107-22
- J Neurosci, 36(16):4534-48
化学信息&溶解度
分子量 | 426.56 |
分子式 | C18H16N6S2.C2H6O |
CAS号 | 1173097-76-1 |
Smiles | CCO.C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N |
储存条件(自收到货起) | |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 85 mg/mL ( 199.26 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 85 mg/mL ( 199.26 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 85 mg/mL ( 199.26 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
5%DMSO
40%PEG300
5%Tween80
50%ddH2O
浓度:4.25mg/ml
(9.96mM)
操作示例:以 1 mL 工作液为例,取50μL85mg/ml的澄清DMSO储备液加到400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μL ddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。